|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's range||126.68 - 126.68|
|52-week range||126.68 - 126.68|
|Beta (5Y monthly)||1.05|
|PE ratio (TTM)||28.50|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Agilent names Allison Ballmer senior vice president of Strategy and Corporate Development.
Agilent (A) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Agilent Technologies Inc. (NYSE: A) announced it has obtained clearance from the Ministry of Health, Labour and Welfare (MHLW) in Japan for the GenetiSure Dx Postnatal Assay – a microarray-based assay for diagnostic use. This assay enables clinical geneticists to detect genetic aberrations associated with developmental delay, intellectual disabilities, congenital anomalies, and unexplained dysmorphic features. The company also announced that it has registered its microarray scanner, SureScan Dx Scanner, as a Class I medical device in Japan, intended for use with the assay.